Lesley Bowman

Lesley is responsible for upstream and downstream process development activities for our latest viral antigen vaccine candidate to combat human cytomegalovirus (CMV).

She joined SpyBiotech in March 2019 from the Sir William Dunn School of Pathology, a department of the University of Oxford, where for five years she worked in collaboration with academic and industrial partners on the pre-clinical development of vaccines that target Shigella, an infectious bacteria that causes severe diarrhoea and dysentery.

Lesley holds a PhD in Microbiology from the University of Sheffield.